Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / FNCH - Finch Therapeutics brings on Roivant Sciences' Matthew Blischak as CEO

FNCH - Finch Therapeutics brings on Roivant Sciences' Matthew Blischak as CEO

Finch Therapeutics Group Inc.

2023-04-25 17:08:37 ET

  • Finch Therapeutics ( NASDAQ: FNCH ) on Tuesday said it had appointed Matthew Blischak as CEO, effective May 16.
  • The company said current CEO Mark Smith will conclude his role as top boss effective May 15.
  • FNCH also announced the appointment of Lance Thibault as CFO.
  • FNCH said Marc Blaustein will conclude his role as chief operating officer and as the company's principal financial officer, effective May 15.
  • According to FNCH, Blischak has more than 20 years of intellectual property experience in the life sciences industry. He joins the company from Roivant Sciences ( ROIV ).

For further details see:

Finch Therapeutics brings on Roivant Sciences' Matthew Blischak as CEO
Stock Information
Company Name: Finch Therapeutics Group Inc.
Stock Symbol: FNCH
Market: NASDAQ
Website: finchtherapeutics.com
Menu
FNCH FNCH Quote FNCH Short FNCH News FNCH Articles FNCH Message Board
Get FNCH Alerts

News, Short Squeeze, Breakout and More Instantly...